Brief

Boehringer Appeals HHS Win In Medicare Drug Price Suit

By Hannah Albarazi · July 29, 2024, 5:25 PM EDT

Boehringer Ingelheim Pharmaceuticals Inc. notified a Connecticut federal court Friday that it will appeal its loss in a lawsuit challenging a new Medicare drug price negotiation program on the grounds that...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Notice of appeal

Case Information

Case Title

Boehringer Ingelheim Pharmaceuticals, Inc. v. United States Department of Health and Human Services et al

Case Number

3:23-cv-01103

Court

Connecticut

Nature of Suit

Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision

Date Filed

August 18, 2023

Recent Articles By Hannah

December 19, 2024
PhRMA Wins Bid To Halt W.Va. Drug Discount Expansion Law
December 17, 2024
NC Panel Revives Negligence Suit Against State Health Dept.
December 10, 2024
Transgender High Court Case Puts Light On Parental Rights
December 04, 2024
Justices Seem To Back Ban On Transgender Youth Care
December 03, 2024
What To Know About High Court's 1st Transgender Care Case
December 03, 2024
FCA Whistleblower Provisions Could Face Peril Under Trump
November 26, 2024
Colo. Panel Weighs In On Faulty Genetic Test Damages
November 20, 2024
Hospital's Med Mal Win Axed By Mich. Appeals Panel
November 15, 2024
Abbott Inks $8M Deal With Healthcare Fraudster In TM Suit
November 04, 2024
DOD Trans Healthcare Denial Discriminates, Judge Rules